Sequential combined crizotinib and camrelizumab in MET-amplified hepatocellular carcinoma
Fields of Study & Subjects
Hepatocellular Carcinoma Treatment and Prognosis
Lung Cancer Treatments and Mutations
Cancer Immunotherapy and Biomarkers
Publication details
- Journal / source
- Genes & Diseases
- Pages
- 102141–102141
- Publication date
- 1 March 2026
- Language
- EN